Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 1
2000 1
2001 1
2003 1
2005 1
2006 3
2007 4
2010 2
2011 3
2012 2
2014 1
2015 1
2017 1
2020 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
Telomere Length Is Predictive of Breast Cancer Risk in BRCA2 Mutation Carriers.
Thorvaldsdottir B, Aradottir M, Stefansson OA, Bodvarsdottir SK, Eyfjörd JE. Thorvaldsdottir B, et al. Among authors: bodvarsdottir sk. Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1248-1254. doi: 10.1158/1055-9965.EPI-16-0946. Epub 2017 Feb 24. Cancer Epidemiol Biomarkers Prev. 2017. PMID: 28235830 Free article.
The effect of sample age on the metabolic information extracted from formalin-fixed and paraffin embedded tissue samples using desorption electrospray ionization mass spectrometry imaging.
Isberg OG, Xiang Y, Bodvarsdottir SK, Jonasson JG, Thorsteinsdottir M, Takats Z. Isberg OG, et al. Among authors: bodvarsdottir sk. J Mass Spectrom Adv Clin Lab. 2021 Oct 28;22:50-55. doi: 10.1016/j.jmsacl.2021.10.004. eCollection 2021 Nov. J Mass Spectrom Adv Clin Lab. 2021. PMID: 34939055 Free PMC article.
AURKA and breast cancer in BRCA1/2 mutation carriers.
Bodvarsdottir SK, Vidarsdottir L, Eyfjord JE. Bodvarsdottir SK, et al. Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2517. doi: 10.1158/1055-9965.EPI-07-0669. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 18006949 Free article. No abstract available.
Aurora A is a prognostic marker for breast cancer arising in BRCA2 mutation carriers.
Aradottir M, Reynisdottir ST, Stefansson OA, Jonasson JG, Sverrisdottir A, Tryggvadottir L, Eyfjord JE, Bodvarsdottir SK. Aradottir M, et al. Among authors: bodvarsdottir sk. J Pathol Clin Res. 2014 Nov 7;1(1):33-40. doi: 10.1002/cjp2.6. eCollection 2015 Jan. J Pathol Clin Res. 2014. PMID: 27499891 Free PMC article.
Sensitivity of BRCA2 mutated human cell lines to Aurora kinase inhibition.
Vidarsdottir L, Steingrimsdottir G, Bodvarsdottir SK, Ogmundsdottir HM, Eyfjord JE. Vidarsdottir L, et al. Among authors: bodvarsdottir sk. Invest New Drugs. 2012 Apr;30(2):425-34. doi: 10.1007/s10637-010-9566-4. Epub 2010 Oct 20. Invest New Drugs. 2012. PMID: 20960027
MYC amplification and TERT expression in breast tumor progression.
Bodvarsdóttir SK, Steinarsdóttir M, Hilmarsdóttir H, Jónasson JG, Eyfjörd JE. Bodvarsdóttir SK, et al. Cancer Genet Cytogenet. 2007 Jul 15;176(2):93-9. doi: 10.1016/j.cancergencyto.2007.04.002. Cancer Genet Cytogenet. 2007. PMID: 17656250
20 results